4hw.com.cn: the words "Lenin", "I am not the God of medicine", and "India's God medicine" have become hot searches recently. Many people are asking why India's generic medicine Lenin is cheap. Let's look at the specific analysis.
"I'm not the God of medicine" is currently occupying the top of the box office with its popularity and high reputation. Many insiders predict that the film will break the box office record again, and Xu Zheng may be the movie's emperor. The reason why the film can be so attractive is not only the excellent lineup, the laughingstock that keeps popping up in the film, but also the profound significance behind the film. The plot line in the film is countless white blood patients, who can't afford to eat the priceless medicine Lenin and can only wait for death. The hero went to India to smuggle generic drugs to save lives, and was finally punished for selling fake drugs.
Why is India's generic medicine Lenin cheap
At first, the patients thought it was a fake drug and refused to take it. Later, they found that the Indian fake drug was really effective, only 1% less than the original anti-cancer drug, Lenin, but the price was too much cheaper, and almost swarmed in. Such a scenario has to be reflected on: why is India's generic medicine so powerful? Why is India's Lenin cheap? Can't China make it by itself?
One of the most impressive words in the film is, 'India is a pharmacy for the poor, so the whole world comes here to buy medicine'. In fact, India's pharmaceutical exports are less than 1 / 3 that of Germany. Why is it called "world pharmacy"?
Known as the "miracle anticancer drug" (called "Lenin" in the film "I am not the God of medicine") is internationally recognized as the first-line treatment drug for chronic myeloid leukemia, which can effectively prolong the life of patients, but patients need to take it for a long time, one box a month, and the price is expensive.
The price of Gleevec produced by Novartis in Switzerland is about 23000-25800 yuan in mainland China, 18000 yuan in Hong Kong, 16000 yuan in Japan, 13600 yuan in the United States and 9700 yuan in South Korea. But India's generic drugs only need more than 200 yuan!
It is reported that India has been working hard to develop its national Biopharmaceutical Enterprises, and the Indian government has also strongly supported their national Biopharmaceutical Enterprises to build India into a 'world pharmacy'. Currently, India produces 20% of the world's generic drugs. With the reputation of high quality and low price, as well as the endorsement of the United Nations, India's generic drugs have risen rapidly in the third world countries. The "good effect and fair price" is people's evaluation of India's generic drugs.
In addition, their technology is reliable. Compared with the original drugs, Indian generic drugs are highly consistent with the original drugs in terms of dosage, effectiveness and safety.
For example, in order to better cure hepatitis C, Gilead, an American pharmaceutical company, continued to develop the second generation (sofibove / redipavir) and the third generation (sofibove / vpatavir) based on sofibove, which made the cure of hepatitis C more simple and the cure rate higher and higher. But Gilead's original research drug is extremely expensive (a course of treatment is 60 to 7.02 million yuan), which is not affordable for families.
India even used its own patent law to directly copy Gilead's sofibwe. Later Gilead learned cleverly and authorized Indian pharmaceutical companies to copy its own sofibwe, the second generation and the third generation (to be listed in India). So there is now a course of about 10000 costs (this is the quotation of the regular channel) to cure hepatitis C.
Can China make 'Indian magic medicine'?
In view of the fact that India's generic drugs have not been approved by China, patients need to take certain risks in purchasing them. So many people ask, why can't China, like India, produce low-cost generic drugs and put them into the market?
Industry insiders explained that the reason why India was able to imitate greavelli is that it has implemented a compulsory patent license, that is, enterprises can forcibly copy patented drugs without the consent of the patentee, so that more patients can buy cheap drugs. In our country, the patent drugs are strictly protected, so the domestic pharmaceutical companies can not copy the drugs within the patent period.
With the expiration of Novartis' patent for leukaemia in 2013, domestic pharmaceutical companies now have alternative drugs on the market at a price of about 3000 yuan, which is still a dozen times higher than the price of generic drugs in India.